Scientific article
Open access

A transcription-based mechanism for oncogenic β-catenin-induced lethality in BRCA1/2-deficient cells

Published inNature communications, vol. 12, no. 1, p. 1-17
Publication date2021-08-13
First online date2021-08-13

BRCA1 or BRCA2 germline mutations predispose to breast, ovarian and other cancers. High-throughput sequencing of tumour genomes revealed that oncogene amplification and BRCA1/2 mutations are mutually exclusive in cancer, however the molecular mechanism underlying this incompatibility remains unknown. Here, we report that activation of β-catenin, an oncogene of the WNT signalling pathway, inhibits proliferation of BRCA1/2-deficient cells. RNA-seq analyses revealed β-catenin-induced discrete transcriptome alterations in BRCA2-deficient cells, including suppression of CDKN1A gene encoding the CDK inhibitor p21. This accelerates G1/S transition, triggering illegitimate origin firing and DNA damage. In addition, β-catenin activation accelerates replication fork progression in BRCA2-deficient cells, which is critically dependent on p21 downregulation. Importantly, we find that upregulated p21 expression is essential for the survival of BRCA2-deficient cells and tumours. Thus, our work demonstrates that β-catenin toxicity in cancer cells with compromised BRCA1/2 function is driven by transcriptional alterations that cause aberrant replication and inflict DNA damage.

Citation (ISO format)
DAGG, Rebecca A. et al. A transcription-based mechanism for oncogenic β-catenin-induced lethality in BRCA1/2-deficient cells. In: Nature communications, 2021, vol. 12, n° 1, p. 1–17. doi: 10.1038/s41467-021-25215-0
Main files (1)
Article (Published version)
ISSN of the journal2041-1723

Technical informations

Creation01/02/2024 2:10:04 PM
First validation01/17/2024 1:37:18 PM
Update time01/17/2024 1:37:18 PM
Status update01/17/2024 1:37:18 PM
Last indexation05/06/2024 5:45:57 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack